Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1986 Dec;60(3):895–901. doi: 10.1128/jvi.60.3.895-901.1986

Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen.

P J Cote, M Shapiro, R E Engle, H Popper, R H Purcell, J L Gerin
PMCID: PMC253316  PMID: 3783820

Abstract

Two chimpanzees immunized with woodchuck hepatitis virus (WHV) surface antigen (WHsAg) developed antibodies cross-reactive with hepatitis B virus (HBV) surface antigen (HBsAg). After challenge with HBV, one animal was completely protected and the other experienced a subclinical infection, without evidence of liver disease. Three woodchucks immunized with HBsAg developed antibodies to HBsAg which did not cross-react with WHsAg. After challenge with WHV, all three woodchucks developed typical acute infections with associated hepatic lesions. Serological studies with the cross-reactive antibodies raised in chimpanzees suggested that the protective epitopes of WHsAg were related to the group a specificity of HBsAg. These studies indicated that cross-protective epitopes are shared by HBV and WHV; however, the humoral response to these epitopes can vary among species.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker L. F., Maynard J. E., Purcell R. H., Hoofnagle J. H., Berquist K. R., London W. T., Gerety R. J., Krushak D. H. Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis. 1975 Oct;132(4):451–458. doi: 10.1093/infdis/132.4.451. [DOI] [PubMed] [Google Scholar]
  2. Berzofsky J. A. Intrinsic and extrinsic factors in protein antigenic structure. Science. 1985 Sep 6;229(4717):932–940. doi: 10.1126/science.2410982. [DOI] [PubMed] [Google Scholar]
  3. Bhatnagar P. K., Papas E., Blum H. E., Milich D. R., Nitecki D., Karels M. J., Vyas G. N. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4400–4404. doi: 10.1073/pnas.79.14.4400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cote P. J., Engle R. E., Langer C. A., Ponzetto A., Gerin J. L. Antigenic analysis of woodchuck hepatitis virus surface antigen with site-specific radioimmunoassays. J Virol. 1984 Mar;49(3):701–708. doi: 10.1128/jvi.49.3.701-708.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cote P. J., Jr, Dapolito G. M., Shih J. W., Gerin J. L. Surface antigenic determinants of mammalian "hepadnaviruses" defined by group- and class-specific monoclonal antibodies. J Virol. 1982 Apr;42(1):135–142. doi: 10.1128/jvi.42.1.135-142.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cote P. J., Jr, Gerin J. L. Nonoverlapping antigenic sites of woodchuck hepatitis virus surface antigen and their cross-reactivity with ground squirrel hepatitis virus and hepatitis B virus surface antigens. J Virol. 1983 Jul;47(1):15–23. doi: 10.1128/jvi.47.1.15-23.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Feitelson M. A., Marion P. L., Robinson W. S. Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus. J Virol. 1981 Aug;39(2):447–454. doi: 10.1128/jvi.39.2.447-454.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Galibert F., Chen T. N., Mandart E. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol. 1982 Jan;41(1):51–65. doi: 10.1128/jvi.41.1.51-65.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gerin J. L., Alexander H., Shih J. W., Purcell R. H., Dapolito G., Engle R., Green N., Sutcliffe J. G., Shinnick T. M., Lerner R. A. Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2365–2369. doi: 10.1073/pnas.80.8.2365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gerin J. L., Faust R. M., Holland P. V. Biophysical characterization of the adr subtype of hepatitis B antigen and preparation of anti-r sera in rabbits. J Immunol. 1975 Jul;115(1):100–105. [PubMed] [Google Scholar]
  11. Heermann K. H., Goldmann U., Schwartz W., Seyffarth T., Baumgarten H., Gerlich W. H. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol. 1984 Nov;52(2):396–402. doi: 10.1128/jvi.52.2.396-402.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ionescu-Matiu I., Kennedy R. C., Sparrow J. T., Culwell A. R., Sanchez Y., Melnick J. L., Dreesman G. R. Epitopes associated with a synthetic hepatitis B surface antigen peptide. J Immunol. 1983 Apr;130(4):1947–1952. [PubMed] [Google Scholar]
  13. Iwarson S., Tabor E., Thomas H. C., Goodall A., Waters J., Snoy P., Shih J. W., Gerety R. J. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. J Med Virol. 1985 May;16(1):89–96. doi: 10.1002/jmv.1890160112. [DOI] [PubMed] [Google Scholar]
  14. Kennedy R. C., Eichberg J. W., Lanford R. E., Dreesman G. R. Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science. 1986 Apr 11;232(4747):220–223. doi: 10.1126/science.3952505. [DOI] [PubMed] [Google Scholar]
  15. Lerner R. A. Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature. 1982 Oct 14;299(5884):593–596. doi: 10.1038/299592a0. [DOI] [PubMed] [Google Scholar]
  16. McAuliffe V. J., Purcell R. H., Gerin J. L. Type B hepatitis: a review of current prospects for a safe and effective vaccine. Rev Infect Dis. 1980 May-Jun;2(3):470–492. doi: 10.1093/clinids/2.3.470. [DOI] [PubMed] [Google Scholar]
  17. Moss B., Smith G. L., Gerin J. L., Purcell R. H. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature. 1984 Sep 6;311(5981):67–69. doi: 10.1038/311067a0. [DOI] [PubMed] [Google Scholar]
  18. Neurath A. R., Kent S. B., Strick N. Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus. Science. 1984 Apr 27;224(4647):392–395. doi: 10.1126/science.6200931. [DOI] [PubMed] [Google Scholar]
  19. Neurath A. R., Kent S. B., Strick N., Taylor P., Stevens C. E. Hepatitis B virus contains pre-S gene-encoded domains. Nature. 1985 May 9;315(6015):154–156. doi: 10.1038/315154a0. [DOI] [PubMed] [Google Scholar]
  20. Peterson D. L., Paul D. A., Lam J., Tribby I. I., Achord D. T. Antigenic structure of hepatitis B surface antigen: identification of the "d" subtype determinant by chemical modification and use of monoclonal antibodies. J Immunol. 1984 Feb;132(2):920–927. [PubMed] [Google Scholar]
  21. Ponzetto A., Cote P. J., Ford E. C., Engle R., Cicmanec J., Shapiro M., Purcell R. H., Gerin J. L. Radioimmunoassay and characterization of woodchuck hepatitis virus core antigen and antibody. Virus Res. 1985 Jun;2(4):301–315. doi: 10.1016/0168-1702(85)90027-9. [DOI] [PubMed] [Google Scholar]
  22. Ponzetto A., Cote P. J., Ford E. C., Purcell R. H., Gerin J. L. Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus. J Virol. 1984 Oct;52(1):70–76. doi: 10.1128/jvi.52.1.70-76.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Popper H., Shih J. W., Gerin J. L., Wong D. C., Hoyer B. H., London W. T., Sly D. L., Purcell R. H. Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. Hepatology. 1981 Mar-Apr;1(2):91–98. doi: 10.1002/hep.1840010202. [DOI] [PubMed] [Google Scholar]
  24. Prince A. M., Brotman B., Purcell R. H., Gerin J. L. A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine. J Med Virol. 1985 Apr;15(4):399–419. doi: 10.1002/jmv.1890150410. [DOI] [PubMed] [Google Scholar]
  25. Purcell R. H., Gerin J. L. Prospects for second and third generation hepatitis B vaccines. Hepatology. 1985 Jan-Feb;5(1):159–163. doi: 10.1002/hep.1840050130. [DOI] [PubMed] [Google Scholar]
  26. Robinson W. S. Genetic variation among hepatitis B and related viruses. Ann N Y Acad Sci. 1980;354:371–378. doi: 10.1111/j.1749-6632.1980.tb27978.x. [DOI] [PubMed] [Google Scholar]
  27. Stannard L. M., Hantz O., Trepo C. Antigenic cross-reactions between woodchuck hepatitis virus and human hepatitis B virus shown by immune electron microscopy. J Gen Virol. 1983 Apr;64(Pt 4):975–980. doi: 10.1099/0022-1317-64-4-975. [DOI] [PubMed] [Google Scholar]
  28. Stibbe W., Gerlich W. H. Structural relationships between minor and major proteins of hepatitis B surface antigen. J Virol. 1983 May;46(2):626–628. doi: 10.1128/jvi.46.2.626-628.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stibbe W., Gerlich W. H. Variable protein composition of hepatitis B surface antigen from different donors. Virology. 1982 Dec;123(2):436–442. doi: 10.1016/0042-6822(82)90275-6. [DOI] [PubMed] [Google Scholar]
  30. Summers J., Smolec J. M., Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4533–4537. doi: 10.1073/pnas.75.9.4533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Summers J. Three recently described animal virus models for human hepatitis B virus. Hepatology. 1981 Mar-Apr;1(2):179–183. doi: 10.1002/hep.1840010215. [DOI] [PubMed] [Google Scholar]
  32. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol. 1978;24:40–69. [PubMed] [Google Scholar]
  33. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Alter H. J., Taylor P. E., DeVera A., Chen G. T., Kellner A. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med. 1982 Dec 9;307(24):1481–1486. doi: 10.1056/NEJM198212093072403. [DOI] [PubMed] [Google Scholar]
  34. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  35. Tabor E., Purcell R. H., Gerety R. J. Primate animal models and titered inocula for the study of human hepatitis A, hepatitis B, and non-A, non-B hepatitis. J Med Primatol. 1983;12(6):305–318. [PubMed] [Google Scholar]
  36. Thung S. N., Gerber M. A., Purcell R. H., London W. T., Mihalik K. B., Popper H. Animal model of human disease. Chimpanzee carriers of hepatitis B virus. Chimpanzee hepatitis B carriers. Am J Pathol. 1981 Dec;105(3):328–332. [PMC free article] [PubMed] [Google Scholar]
  37. Wands J. R., Wong M. A., Shorey J., Brown R. D., Marciniak R. A., Isselbacher K. J. Hepatitis B viral antigenic structure: signature analysis by monoclonal radioimmunoassays. Proc Natl Acad Sci U S A. 1984 Apr;81(7):2237–2241. doi: 10.1073/pnas.81.7.2237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Werner B. G., Smolec J. M., Snyder R., Summers J. Serological relationship of woodchuck hepatitis virus to human hepatitis B virus. J Virol. 1979 Oct;32(1):314–322. doi: 10.1128/jvi.32.1.314-322.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wong D. C., Shih J. W., Purcell R. H., Gerin J. L., London W. T. Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck surface antigen and antibody. J Clin Microbiol. 1982 Mar;15(3):484–490. doi: 10.1128/jcm.15.3.484-490.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Xu Z. Y., Liu C. B., Francis D. P., Purcell R. H., Gun Z. L., Duan S. C., Chen R. J., Margolis H. S., Huang C. H., Maynard J. E. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics. 1985 Nov;76(5):713–718. [PubMed] [Google Scholar]
  41. Zahradnik J. M., Heiberg D., Hollinger F. B. Hepatitis B vaccine: immune responses in children from families with an HBsAg carrier. Vaccine. 1985 Dec;3(5):407–413. doi: 10.1016/0264-410x(85)90132-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES